LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $547,010 | -15.1% | 9,129 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $644,358 | +5.3% | 8,937 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $611,651 | +10.5% | 8,315 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $553,438 | -23.0% | 8,285 | -0.8% | 0.00% | -20.0% |
| Q3 2022 | $719,000 | -3.1% | 8,350 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $742,000 | -24.7% | 8,321 | -5.1% | 0.01% | 0.0% |
| Q1 2022 | $986,000 | -31.3% | 8,765 | -5.7% | 0.01% | -28.6% |
| Q4 2021 | $1,436,000 | +7.4% | 9,295 | -3.1% | 0.01% | 0.0% |
| Q3 2021 | $1,337,000 | -73.1% | 9,594 | -74.6% | 0.01% | -58.8% |
| Q2 2021 | $4,962,000 | -15.0% | 37,824 | -1.3% | 0.02% | -15.0% |
| Q1 2021 | $5,841,000 | +57.9% | 38,315 | +3.0% | 0.02% | +42.9% |
| Q4 2020 | $3,699,000 | +2.4% | 37,194 | -1.8% | 0.01% | -17.6% |
| Q3 2020 | $3,611,000 | -16.4% | 37,886 | -1.9% | 0.02% | -19.0% |
| Q2 2020 | $4,318,000 | +41.2% | 38,602 | -8.2% | 0.02% | +23.5% |
| Q1 2020 | $3,058,000 | -33.9% | 42,052 | -5.2% | 0.02% | -5.6% |
| Q4 2019 | $4,624,000 | -2.9% | 44,339 | -7.4% | 0.02% | -5.3% |
| Q3 2019 | $4,764,000 | -16.7% | 47,862 | -4.5% | 0.02% | -13.6% |
| Q2 2019 | $5,721,000 | -15.3% | 50,118 | -6.8% | 0.02% | -15.4% |
| Q1 2019 | $6,758,000 | -12.2% | 53,762 | -5.2% | 0.03% | -18.8% |
| Q4 2018 | $7,695,000 | +70.4% | 56,709 | +244.8% | 0.03% | +113.3% |
| Q3 2018 | $4,515,000 | +34.8% | 16,449 | +1.8% | 0.02% | +25.0% |
| Q2 2018 | $3,349,000 | +54.8% | 16,166 | +23.4% | 0.01% | +50.0% |
| Q1 2018 | $2,164,000 | -3.5% | 13,104 | -20.0% | 0.01% | +14.3% |
| Q4 2017 | $2,242,000 | +1.1% | 16,370 | +0.5% | 0.01% | -12.5% |
| Q3 2017 | $2,217,000 | +20.4% | 16,282 | +7.4% | 0.01% | +14.3% |
| Q2 2017 | $1,841,000 | +50.7% | 15,161 | +31.3% | 0.01% | +75.0% |
| Q1 2017 | $1,222,000 | -13.8% | 11,544 | -17.3% | 0.00% | -20.0% |
| Q4 2016 | $1,418,000 | -99.9% | 13,954 | -1.4% | 0.01% | -16.7% |
| Q3 2016 | $1,444,455,000 | -14.5% | 14,153 | -0.0% | 0.01% | -14.3% |
| Q2 2016 | $1,688,625,000 | +17.3% | 14,158 | +5.4% | 0.01% | +16.7% |
| Q1 2016 | $1,439,000,000 | +3.6% | 13,431 | +4.8% | 0.01% | 0.0% |
| Q4 2015 | $1,389,000,000 | +127918.4% | 12,810 | +1.2% | 0.01% | +20.0% |
| Q3 2015 | $1,085,000 | -99.9% | 12,661 | +1.2% | 0.01% | 0.0% |
| Q2 2015 | $1,262,058,000 | +12.7% | 12,508 | -13.8% | 0.01% | 0.0% |
| Q1 2015 | $1,119,483,000 | +45.3% | 14,518 | +0.3% | 0.01% | +66.7% |
| Q4 2014 | $770,268,000 | +4.4% | 14,476 | -7.8% | 0.00% | 0.0% |
| Q3 2014 | $737,978,000 | -27.0% | 15,705 | -3.2% | 0.00% | -25.0% |
| Q2 2014 | $1,010,593,000 | +2.9% | 16,224 | +11.1% | 0.00% | -20.0% |
| Q1 2014 | $981,865,000 | +24.5% | 14,598 | -2.6% | 0.01% | +25.0% |
| Q4 2013 | $788,579,000 | +52.6% | 14,992 | +25.5% | 0.00% | +33.3% |
| Q3 2013 | $516,850,000 | +15.2% | 11,942 | -0.4% | 0.00% | 0.0% |
| Q2 2013 | $448,591,000 | – | 11,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |